Skip to main content
Clinical Trials/NCT05678114
NCT05678114
Completed
Not Applicable

The Effect of Inositol Treatment in Women With PCOS of Different Phenotype

Lo.Li.Pharma s.r.l1 site in 1 country120 target enrollmentDecember 21, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Polycystic Ovary Syndrome
Sponsor
Lo.Li.Pharma s.r.l
Enrollment
120
Locations
1
Primary Endpoint
Regularization of the menstrual cycle
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Evaluation of the efficacy of inositol treatment in women with PCOS in relation to the phenotype (according to the Rotterdam Criteria)

Registry
clinicaltrials.gov
Start Date
December 21, 2022
End Date
May 12, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • women with PCOS of any phenotype

Exclusion Criteria

  • hormonal treatment (such as contraceptive pill)
  • use of supplements containing myo-inositol
  • severe co-morbidities

Outcomes

Primary Outcomes

Regularization of the menstrual cycle

Time Frame: Change from baseline number of women with irregular menstrual cycle at 4 months

Number of women with regular/altered menstrual cycle

Study Sites (1)

Loading locations...

Similar Trials